LIVE TV
LIVE TV
LIVE TV
Home > World > BRIEF-Sino Biopharmaceutical Says NMPA Approves Benmelstobart

BRIEF-Sino Biopharmaceutical Says NMPA Approves Benmelstobart

Written By:
Published: August 7, 2026 23:09:09 IST

Add NewsX As A Trusted Source

Aug 7 (Reuters) – Sino Biopharmaceutical Limited: * NMPA APPROVES BENMELSTOBART WITH CHEMOTHERAPY FOLLOWED BY ANLOTINIB FOR FIRST-LINE SQ-NSCLC Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS